HIF3A anticorps (C-Term)
Aperçu rapide pour HIF3A anticorps (C-Term) (ABIN203237)
Antigène
Voir toutes HIF3A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Human HIF3A
-
Homologie
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Protein A/G purified
-
Immunogène
-
Synthetic peptide from C-Terminus of human HIF3A (Q9Y2N7, NP_690007). Percent identity by BLAST analysis: Human, Gorilla (100%), Gibbon (92%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P, WB (1.25 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- HIF3A (Hypoxia Inducible Factor 3, alpha Subunit (HIF3A))
-
Autre désignation
- HIF3A / HIF3-Alpha
-
Sujet
-
Name/Gene ID: HIF3A
Synonyms: HIF3A, BHLHe17, HIF-3A, IPAS, HIF3-alpha-1, Inhibitory PAS domain protein, PASD7, HIF-3-alpha, HIF3-alpha, Member of PAS protein 7, MOP7 -
ID gène
- 64344
-
NCBI Accession
- NP_690007
-
UniProt
- Q9Y2N7
-
Pathways
- L'effet Warburg
Antigène
-